Buy 4fma 60 mg (4-Fluoromethamphetamine) – Scientific Product Description

Introduction

Buy 4fma, 4-Fluoromethamphetamine (4-FMA) is a fluorinated compound of the phenethylamine class. This research substance was developed for controlled pharmacological and neurochemical research. The 60 mg pellets provide a standardized form for dosage research and analytical use.

Tekniset tiedot

• Chemical structure: 1-(4-fluorophenyl)-2-(methylamino)propane
• Molecular formula: C₁₀H₁₄FN
• Molecular mass: 167.23 g/mol

Pellet characteristics

• Active ingredient: 60.0 ± 2.4 mg 4-FMA hydrochloride
• Excipients: Microcrystalline cellulose, magnesium stearate
• Purity of active substance: ≥98.5% (UPLC-MS/MS)
• Halkaisija: 6 mm
• Hardness: 50–80 N
• In vitro disintegration time: <15 minutes

Quality control

Each batch undergoes:

• HPLC-DAD analysis (quantification)
• MS confirmation (structure verification)
• Uniformity test (n=20 pellets)
• Dissolution test according to USP (Apparatus II)
• Microbiological purity analysis

Tutkimussovellukset

The 4-FMA pellets are used for:

• Transporter affinity study (dopamine, serotonin)
• Comparative pharmacokinetics with related compounds
• In vitro dose-response studies
• Behavioral studies under controlled conditions

Safety protocols

Personal protection

• Protective clothing (type 5)
• Chemical resistant nitrile gloves
• FFP3 respiratory protection

Laboratory environment

• Fume hood with air velocity ≥0.8 m/s
• Grounded work surfaces (static control)
• ATEX-classified equipment if required

Säilytysolosuhteet

• Temperature: 15–25°C
• Humidity: <40% relative humidity
• Packaging: Amber containers, airtight sealed

Regulatory Framework

• Classified under the Dutch Opium Act (Schedule II)
• Subject to EU regulations on new psychoactive substances
• Classified as a banned substance under WADA (Class S6)
• Only available for licensed research institutions

Distribution terms and conditions

• Minimum order quantity: 10 pellets
• Packaging: Individually blister packed
• Transport: Refrigerated with temperature registration
• Documentation included:
  • Analyysitodistus (COA)
  • Stability Report
  • Käyttöturvallisuustiedote (MSDS)

Reference research

• EMCDDA (2023) – Monitoring and Risk Assessment
• Analyyttisen toksikologian lehti (2022)
• Psykofarmakologia (2021)

Legal Disclaimer

This product is intended solely for scientific research within legally accredited laboratories. Not intended for human or veterinary consumption. The end user is solely responsible for compliance with applicable laws and regulations. Unauthorized use is prohibited and punishable by law.

on 6-CL-ADBA 2C-EF 2 mg kapselit 2-CMC 250 mg -pellettiä 1V-LSD 150 MCG -näytteenotot